Health · 1 sources covering this

Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer

Merck presented its mRNA melanoma vaccine trial data at a European cancer conference this weekend. Results are promising: The vaccine reduces recurrence and death alongside an immunotherapy drug.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

NPRLean L·1h ago
Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer
Merck presented its mRNA melanoma vaccine trial data at a European cancer conference this weekend. Results are promising: The vaccine reduces recurrence and death alongside an immunotherapy drug.
Read at NPR →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/d11befd95422e58c506664ade6589d9362b1281f"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer"></iframe>

Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer

How 1 sources are covering this

Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer

More from Health

Special ed diaries: Teachers tell NPR about their most joyous, most difficult moments

The 4 stages of women’s heart health: Experts present new framework

Many Medicare Patients Could Lose Access to Remote Monitoring Devices

The Cost of Healthcare Is Hitting America Where It Hurts: The Wallet

Reader

Trust & legal

Across the network